Efficacy and Safety of Direct-acting Antivirals in Hepatitis C Virus-infected Patients Taking Proton Pump Inhibitors

Background and Aims: Direct-acting antiviral (DAA) therapy is the cornerstone of the treatment of chronic hepatitis C virus (HCV) infection. Eradication of HCV, predicted by the attainment of a sustained virologic response (SVR) 12 weeks following DAA therapy, is the goal of this treatment. Interest...

Descripción completa

Detalles Bibliográficos
Autores principales: Wijarnpreecha, Karn, Chesdachai, Supavit, Thongprayoon, Charat, Jaruvongvanich, Veeravich, Ungprasert, Patompong, Cheungpasitporn, Wisit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719190/
https://www.ncbi.nlm.nih.gov/pubmed/29226099
http://dx.doi.org/10.14218/JCTH.2017.00017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719190/
https://www.ncbi.nlm.nih.gov/pubmed/29226099
http://dx.doi.org/10.14218/JCTH.2017.00017

Ejemplares similares